CNBX - Cannabics gets notice of allowance from the Mexican Patent and Trademark Office

Cannabics Pharmaceuticals (CNBX) has received "Notice of Allowance" from the Mexican Patent and Trademark Office ((IMPI)) in relation to the company's patent titled: 'System and method for high throughput screening of cancer cells'.The decision of the Mexican patent authority follows the European Patent Office ((EPO)) "Intention to Grant a European Patent" notice to the company from October 2020, concerning the same patent application, the company said.

For further details see:

Cannabics gets "notice of allowance" from the Mexican Patent and Trademark Office